How Structured Surveillance Kept a Compensated Cirrhosis Patient Free from Decompensation
Patient Profile
Field | Details |
Age | 52 years |
Gender | Male |
Occupation | Bank employee |
City | Pune |
Presenting Complaint | Mild fatigue and an incidental finding of an enlarged spleen and low platelet count on a routine blood test |
Diagnosis | Compensated liver cirrhosis with portal hypertension, related to long standing fatty liver disease |
Duration of Issue | Underlying liver changes likely present for several years before detection |
Previous Treatments | None, condition was previously undiagnosed |
Date of Procedure | March 2026, managed on an ongoing outpatient basis |
Outcome | Excellent, patient remains compensated with no signs of decompensation |
The Problem
Condition
Liver cirrhosis develops when long standing liver injury causes healthy tissue to be replaced with scar tissue, gradually reducing the organ’s ability to filter blood and produce essential proteins. This patient had reached a compensated stage of liver cirrhosis, meaning the liver was still managing its core functions despite significant scarring, and portal hypertension, a rise in pressure within the vein carrying blood to the liver, was already present. The condition was identified incidentally through a low platelet count and an enlarged spleen on ultrasound, well before any of the more visible signs typically associated with advanced liver disease appeared.
Emotional & Psychological Impact
The diagnosis came as a shock to a man who considered himself generally healthy and had no history of heavy alcohol use. He had assumed his tiredness was simply due to long working hours, not realising that untreated fatty liver changes over several years had quietly progressed to scarring of the liver. Learning that this damage was already present, even without any dramatic symptoms, left him uncertain about what the future held for his health and his family responsibilities. He was reassured to learn he was being guided by a trusted Gastroenterologist in Pune, and clear explanation of his stage of disease helped settle his initial worry over the following weeks.
Consultation & Treatment Plan
What Was Assessed During the Consultation?
- Complete liver function tests, complete blood count, and coagulation profile to establish baseline liver reserve
- Abdominal ultrasound and elastography to confirm the degree of fibrosis and spleen size
- Upper gastrointestinal endoscopy to screen for oesophageal varices associated with portal hypertension
- Child Pugh and MELD scoring to classify the stage of liver disease and guide monitoring frequency
- Review of metabolic risk factors, including weight, blood sugar, and lipid profile, given the fatty liver background
Why This Surveillance Led Approach Was Chosen
Dr. Kothari selected a proactive surveillance and risk reduction strategy rather than waiting for symptoms of decompensation to appear. The reasoning behind this decision included the following points.
- Identifying varices early through screening endoscopy allows preventive treatment before a bleeding episode occurs, one of the most dangerous complications of portal hypertension
- Regular monitoring of liver function and spleen size helps detect early signs of disease progression while intervention options remain broader
- Addressing the metabolic drivers behind the fatty liver disease directly targets the root cause rather than only managing symptoms as they arise
- A structured review calendar, rather than reactive care, is recognised as the most reliable way to keep a compensated patient in that stage for as long as possible
Baseline Imaging & Documentation
Baseline evaluation documents the starting clinical picture and anchors the entire surveillance plan. Tests were performed under standard fasting conditions to ensure accurate liver function and elastography readings before any treatment adjustments began.
Management Protocol:- Step by Step
- Baseline liver function and imaging assessment completed at the first consultation
- Screening upper endoscopy performed to check for varices and assess bleeding risk
- Beta blocker therapy considered where indicated to reduce portal pressure and lower bleeding risk
- Dietary counselling introduced to support a low sodium intake and reduce the future risk of fluid retention
- Structured lifestyle guidance provided to address the underlying metabolic contributors to liver scarring
- Review schedule established with repeat blood work, imaging, and endoscopy at defined intervals
Management Facts
Field | Details |
Setting | Outpatient, no hospital admission required |
Anaesthesia | Mild sedation only for the screening endoscopy |
Key Diagnostic Tool | Elastography, endoscopy, and Child Pugh scoring |
Approach | Structured surveillance with risk factor management |
Complications | None |
Review Frequency | Every three to six months depending on findings |
Outcomes at a Glance
| Outcome Metric | Result |
| Variceal Risk | Low grade, no urgent intervention needed |
| Liver Function | Stable across review visits |
| Decompensation Signs | None observed |
| Metabolic Control | Improved with lifestyle changes |
| Patient Satisfaction | Very high, reassured by regular monitoring |
Ongoing Care & Maintenance
Instructions Given to Patient
- Maintain a low sodium, liver friendly diet to reduce the risk of future fluid retention
- Avoid alcohol completely and continue working on metabolic risk factors such as weight and blood sugar
- Take prescribed medication consistently to help control portal pressure
- Attend all scheduled blood tests, imaging, and endoscopy reviews without delay
- Report any new swelling, confusion, or dark stools immediately rather than waiting for the next visit
Recovery & Monitoring Timeline
| Timeframe | What Patient Could Expect |
| Month 1 | Baseline results reviewed, monitoring plan finalised |
| Month 3 | First review blood work to confirm stability |
| Month 6 | Repeat imaging and reassessment of spleen size and liver stiffness |
| Month 9 to 12 | Repeat screening endoscopy to reassess variceal status |
| Ongoing | Continued periodic monitoring to sustain the compensated stage |
Patient Feedback
“Finding out I had cirrhosis without ever feeling seriously unwell was hard to process at first. What made the biggest difference was having a clear plan and regular checks, rather than just being told to come back if something went wrong. I feel far more in control of my health now than I did before the diagnosis.”
Profile: Male, 52 years, Bank employee, Pune
Procedure: Structured surveillance and risk reduction for compensated cirrhosis with portal hypertension, Pune, March 2026 Surgeon: Dr. Ksheetij Kothari, Consultant Gastroenterologist
Disclaimer: The information shared in this content is for educational purposes only and not for promotional use.